The EIB and Utrecht-based AM-Pharma have signed a €24 million financing agreement. The funds will be used to accelerate the development of the clinical stage biopharmaceutical company’s recombinant alkaline phosphatase enzyme, which is used to treat acute kidney injury (AKI). The...
Yuichiro Akita, President of the Berne Union and senior general manager, international strategic policy, at Nippon Export and Investment Insurance (NEXI) discusses the...
New nuclear’s construction risk and development timelines have made it difficult to bank – until now. The RAB revenue model means that Sizewell C’s funding package includes an...
TXF spoke with PuiYin Tham, vice president of business development at Marubeni to outline the benefits of taking the ECA funding route and how the Japanese developer’s deal pipeline is shaping up in the APAC region.
Yuichiro Akita, President of the Berne Union and senior general manager, international strategic policy, at Nippon Export and Investment Insurance (NEXI) discusses the necessity of adaptability with TXF at the Berne Union’s AGM in Ottawa.
New nuclear’s construction risk and development timelines have made it difficult to bank – until now. The RAB revenue model means that Sizewell C’s funding package includes an ECA-covered bank piece, but RAB may not provide value for money.
Connecting the Middle East and Africa. Step into the vibrant world of trade, agency and project finance at Exile’s (TXF, Proximo and Uxolo) MEA 2026.
View more
Unveil Amsterdam's allure! Elevate your pipeline with top dealmakers. An Industry Awards dinner adds glamour to this unmissable adventure.
View more